ANGLE Technology Ventures

• ANGLE CTC Lab Services ► OverviewEnumeration of epithelial and mesenchymal CTC populationsMultiplex gene expression profiling of CTC populations ► Performance PD-L1 analysis of CTC populationsCustom CTC assays
• ANGLE CTC Lab Services
• Enumeration of epithelial and mesenchymal CTC populations
• Multiplex gene expression profiling of CTC populations ► Performance
• PD-L1 analysis of CTC populations
• Translational Research ► Women's Health ► Ovarian CancerBreast Cancer Men's Health ► Prostate Cancer Other ► Low Volume for Animal Models
• Women's Health ► Ovarian CancerBreast Cancer
• Other ► Low Volume for Animal Models
• Low Volume for Animal Models
• Resources ► Product Information ► Product InformationBrochuresApplication NotesInstrument User Guides Publications ► PostersArticlesWhitepapersPresentations Webinars
• Product Information ► Product InformationBrochuresApplication NotesInstrument User Guides
• Investor Relations ► Regulatory News ► Regulatory News Share PriceCorporate Presentations & Webcasts ► Corporate Presentations & WebcastsMediaAnalyst Research Financial Reports ► Financial ReportsGeneral Meetings DocumentationFinancial Calendar Corporate Responsibility ReportsAIM Rule 26 ► AIM RuleCorporate GovernanceSignificant ShareholdersADRAdvisors GlossaryEmail Alert
• Corporate Presentations & Webcasts ► Corporate Presentations & WebcastsMediaAnalyst Research
• Corporate Presentations & Webcasts
• Financial Reports ► Financial ReportsGeneral Meetings DocumentationFinancial Calendar
• AIM Rule 26 ► AIM RuleCorporate GovernanceSignificant ShareholdersADRAdvisors

The Parsortix® PC1 Clinical System

Building a differentiated position in the multi-billion dollar liquid biopsy market

With advancements in genomics and clinical information there has been a paradigm shift from “one drug fits all” towards “precision medicine” – the right drug for the right patient at the right time

The Parsortix system is easy to use and can be used with whole blood samples, direct from a simple blood test, without any pre-processing of the blood such as red blood cell removal This makes the process easy and cost effective whilst ensuring unnecessary loss of target cells is minimized For Research Use Only- Not for use in clinical diagnostic procedures

Read about how Parsortix® is being used in research Head to our investor centre to find current financial information, our corporate calendar, stock information and corporate governance